Carmot Therapeutics Inc. (CRMO)

Carmot Therapeutics was planning to go public, but the IPO was withdrawn on Dec 11, 2023.

Stock Price: Pending

IPO price not available yet

Carmot Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021
Debt / Equity Ratio	-0.06	-0.06	-1.17
Debt / EBITDA Ratio	-0.09	-0.10	1.16
Debt / FCF Ratio	-0.07	-0.10	-1.22
Quick Ratio	11.87	11.87	1.34
Interest Coverage	-7.97	-	-
Return on Equity (ROE)	81.13%	60.96%	-98.68%
Return on Assets (ROA)	-	-22.20%	33.49%
Return on Capital (ROIC)	112.63%	72.80%	-528.92%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).